South Korea vs Mongolia: Number of isolates tested for ceftriaxone
South Korea
115
in 2018
Mongolia
129
in 2018
South Korea rank
25th
Mongolia rank
24th
Number of isolates tested for ceftriaxone over time
- South Korea
- Mongolia
How they compare
Mongolia currently reports 129 against 115 in South Korea, a difference of 14.
That makes Mongolia's figure about 1.1 times South Korea's.
The two have swapped places 2 times across 6 shared years of data; in 2009 it was Mongolia ahead.
South Korea ranks 25th and Mongolia ranks 24th of 52 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82 | 690 | 608 | Mongolia |
| 2010s | 67.6 | 210.2 | 142.6 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, South Korea or Mongolia?
- Mongolia, at 129 against 115 in South Korea as of 2018.
- What is the difference in number of isolates tested for ceftriaxone between South Korea and Mongolia?
- 14, with Mongolia ahead.
- How many years of comparable data are there for South Korea and Mongolia?
- 6 years are reported by both, from 2009 to 2018.
- How do South Korea and Mongolia rank globally for number of isolates tested for ceftriaxone?
- South Korea ranks 25th and Mongolia ranks 24th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.